Brain Tumours

Pituitary

748

Number of patients

27.3 years (range, 10.8-47.7)

FU period

46.5% 10.8%

Prevalence GHD

Prevalence LH/FSHD Prevalence TSHD Prevalence ACTHD Treatment of GHD Treatment LH/FSHD

7.5%

4%

0.3%

21.5%

03/01/13